Local Institution

Manchester M23 9LT

0 studies enrolling now · 7 studies all time

What they study most

Melanoma, Non-small Cell Lung Cancer, Renal Transplantation, Rheumatoid Arthritis, Skin Cancer, Thrombosis, Type 2 Diabetes Mellitus

Studies at this site

• A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation — Completed
• An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma — Completed
• Effects of Abatacept in Patients With Early Rheumatoid Arthritis — Completed
• Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants — Withdrawn before enrolling
• Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes — Completed
• Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant — Completed
• Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer — Stopped early